Managing the multifaceted nature of type 2 diabetes using once‐weekly injectable GLP‐1 receptor agonist therapy

Author:

Bzowyckyj Andrew1ORCID

Affiliation:

1. Pacific University Oregon School of Pharmacy Hillsboro OR USA

Funder

Novo Nordisk Inc.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference92 articles.

1. International Diabetes Federation.IDF Diabetes Atlas Ninth edition.2019.https://www.idf.org/e-library/epidemiology-research/diabetes-atlas/159-idf-diabetes-atlas-ninth-edition-2019.html. Accessed April 21 2020.

2. Centers for Disease Control and Prevention.National diabetes statistics report 2017: estimates of diabetes and its burden in the United States.2017.https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf. Accessed June 3 2019.

3. Diabetes-attributable mortality in the United States from 2003 to 2016 using a multiple-cause-of-death approach

4. Prevalence of Diagnosed Diabetes in Adults by Diabetes Type — United States, 2016

5. Prevalence and Incidence Trends for Diagnosed Diabetes Among Adults Aged 20 to 79 Years, United States, 1980-2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3